Marshall Wace’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Buy |
+25,537
| New | +$1.3M | ﹤0.01% | 1632 |
|
|
2025
Q1 | – | Sell |
-175,913
| Closed | -$7.27M | – | 2731 |
|
|
2024
Q4 | $7.27M | Buy |
175,913
+152,191
| +642% | +$6.29M | 0.01% | 841 |
|
|
2024
Q3 | $925K | Buy |
23,722
+3,202
| +16% | +$125K | ﹤0.01% | 1549 |
|
|
2024
Q2 | $702K | Buy |
20,520
+5,420
| +36% | +$185K | ﹤0.01% | 1653 |
|
|
2024
Q1 | $379K | Buy |
+15,100
| New | +$379K | ﹤0.01% | 1784 |
|
|
2022
Q3 | – | Sell |
-10,960
| Closed | -$214K | – | 2878 |
|
|
2022
Q2 | $214K | Buy |
+10,960
| New | +$214K | ﹤0.01% | 2448 |
|
|
2022
Q1 | – | Sell |
-52,527
| Closed | -$839K | – | 3021 |
|
|
2021
Q4 | $839K | Sell |
52,527
-16,982
| -24% | -$271K | ﹤0.01% | 1968 |
|
|
2021
Q3 | $1.38M | Buy |
+69,509
| New | +$1.38M | 0.01% | 1398 |
|